ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003

NCI To Expand Funds for Cancer Centers, SPOREs, Director Tells House Appropriators

March 29, 2002

DRCA Board Split On Use Of Cancer Control Funds By Centers; NCAB Probably Will Decide The Issue

November 26, 1982

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008